Dorsey Wright & Associates
- SEC CIK
- 0001376772
- Latest filing
- Aug 6, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by Dorsey Wright & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −1,375−100.0% | Sold out | Holders |
| Q2 2023 | 1,375 | $28.1K | <0.1% | +138+11.2% | Added | Holders |
| Q1 2023 | 1,237 | $27.1K | <0.1% | −4,263−77.5% | Reduced | Holders |
| Q4 2022 | 5,500 | $22.5K | <0.1% | – | No prior filing | Holders |